Search - tctmd.com

Displaying 81 - 100 of 704

Sort: Relevancy | Date

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Conference News HFSA 2024

FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?

Michael O'Riordan

October 02, 2024

News Daily News

HFSA Stats 2024 a ‘Call to Action’ Against Rising Tide of HF

L.A. McKeown

October 01, 2024

News Daily News

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Michael O'Riordan

September 27, 2024

News Daily News

Low Adherence to Secondary Prevention Recommendations Worldwide: INTERASPIRE

Yael L. Maxwell

September 23, 2024

News Conference News ESC 2024

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

Michael O'Riordan

September 01, 2024

News Conference News ESC 2024

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

Michael O'Riordan

September 01, 2024

News Conference News ESC 2024

New BedMed Data Confirm Antihypertensives Can Be Taken Any Time of Day

Yael L. Maxwell

August 31, 2024

News Conference News ESC 2024

ABYSS: Safety Signal Seen When Beta-blockers Stopped in Post-MI Patients

Michael O'Riordan

August 30, 2024

News Daily News

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Michael O'Riordan

August 26, 2024

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Daily News

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Yael L. Maxwell

August 15, 2024

News Daily News

Scoring System Puts Focus on Medical Therapy Optimization in HFrEF

L.A. McKeown

August 13, 2024

News Daily News

ACC Offers Guidance for Remote Patient Monitoring

L.A. McKeown

August 06, 2024

News Daily News

FINEARTS-HF: Topline Results Support Role for Finerenone in Mildly Reduced or Preserved EF

L.A. McKeown

August 05, 2024

News Daily News

SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results

Yael L. Maxwell

August 01, 2024

News Daily News

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

Michael O'Riordan

July 26, 2024

News Daily News

For Pragmatic RCTs, Patient-Reported ‘Hard’ Events Fall Short

L.A. McKeown

July 25, 2024

News Daily News

ECG Abnormalities on Routine Screening Tied to CVD Events in Large Study

Todd Neale

July 05, 2024

Advertisement

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

What’s Going to Be Big at TCT 2024?

FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?

HFSA Stats 2024 a ‘Call to Action’ Against Rising Tide of HF

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Low Adherence to Secondary Prevention Recommendations Worldwide: INTERASPIRE

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

New BedMed Data Confirm Antihypertensives Can Be Taken Any Time of Day

ABYSS: Safety Signal Seen When Beta-blockers Stopped in Post-MI Patients

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Scoring System Puts Focus on Medical Therapy Optimization in HFrEF

ACC Offers Guidance for Remote Patient Monitoring

FINEARTS-HF: Topline Results Support Role for Finerenone in Mildly Reduced or Preserved EF

SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results

Reduced Vascular Load, Better RV Function With Dapagliflozin in HFpEF

For Pragmatic RCTs, Patient-Reported ‘Hard’ Events Fall Short

ECG Abnormalities on Routine Screening Tied to CVD Events in Large Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content